Head-to-head · Cost-Efficiency Index
FitRx vs AskRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
FitRx
Cost-first shoppers who want insured patients trying to unlock brand-name GLP-1 access below list price.
Visit FitRxAskRx
Patients who specifically want FDA-approved branded Wegovy/Zepbound/Foundayo and don't need to see the drug price before starting intake.
Visit AskRxThe verdict
FitRx and AskRx tie on the Cost-Efficiency Index at 59/100, so neither wins outright on the numbers. For most shoppers we'd start with FitRx (ranked #265, a hair above #266) — Cost-first shoppers who want insured patients trying to unlock brand-name GLP-1 access below list price. But AskRx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs FitRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | FitRx | AskRx |
|---|---|---|
| Cost-Efficiency Index | 59/100 | 59/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #265 | #266 |
FitRx
59/100Where the value is
- All 50 states + DC coverage
- LegitScript certified
- All four major brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) available if insurance coordination succeeds
The tradeoffs
- The headline '$25/month' price is not a standing self-pay rate — it's an insurance-dependent outcome the site itself hedges with 'roughly', so most uninsured shoppers will pay $151/mo instead
- No compounded tirzepatide offered at all — semaglutide-only on the compounded side
Regulatory note: the FDA issued a warning letter to FitRX, LLC dba FitRx in February 2026. We still list and link to FitRx; you should know the letter is on the public record before you decide.
AskRx
59/100Where the value is
- Sells only FDA-approved branded medication ('never compounded'), removing compounding-related sourcing questions entirely
- States a clear, itemized flat care fee ($90 visit + $10 fulfillment = $100/mo) rather than folding an undisclosed markup into the drug price
- Explicitly states no markup is added to the medication's pharmacy cost
The tradeoffs
- The actual medication price — the majority of the real monthly cost for a brand-name GLP-1 — is never published; it's shown only at checkout after intake, so the site cannot be used to comparison-shop the true total cost
- Live video visits are limited to 'select states' despite the blanket '50 States' coverage claim, an inconsistency the site doesn't reconcile
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.